Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Aural Analytics, Signant Health to Integrate A2E SDK for Current and Future Clinical Trials.

Document Cited in Related
Vincent

INTERNET BUSINESS NEWS-(C)1995-2020 M2 COMMUNICATIONS

Aural Analytics, Inc., an industry speech neuroscience and speech analytics technology company, has announced it has partnered with Signant Health (Signant) to integrate its A2E(TM) mobile application SDK and Web API across Signant Health's Rater Station(TM) and TrialMax[R] training, data quality monitoring and eCOA solutions, the company said.

A2E is designed to make clinical-grade speech collection and cloud-based analytics ubiquitous across the lifespan and continuum of care.

The partnership begins in service of a global, late phase study in Major Depressive Disorder (MDD), with several more studies planned for development. The initial integration enables 14 languages and in-clinic and remote voice collection. Ultimately the A2E system will power a full suite of speech analytics for the sponsoring pharmaceutical company.

The A2E technology is based on nearly 30 years of speech neuroscience research and includes a mobile application SDK with cloud-based computation that powers disease-specific speech tasks and analytics for use in clinical trials, telemedicine, remote monitoring and consumer applications. A2E is currently available for integration into iOS, Android and web-based applications, with modules available for neurology and respiratory disease.

Signant Health and its sponsor customers will also take advantage of a robust online portal that...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT